Skip to main content
Fig. 3 | European Journal of Medical Research

Fig. 3

From: Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice

Fig. 3

Treatment with BIBF1000 reduced: A, B allergen-induced lung tissue mRNA expression of TNF-α and IL-1β; C lung tissue MUC5AC content, and the contents of cys-leukotrienes in lavage fluid. All values are mean ± SEM, n = 8. #p < 0.05 vs. control, *p < 0.05 vs. vehicle

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us